ORKA Earnings Oruka Therapeutics, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–20 of 20
| Q2 2025 | 2025-06-30 | -0.85 | 2025-08-11 | 10-Q |
| Q1 2025 | 2025-03-31 | -0.40 | 2025-05-14 | 10-Q |
| FY 2024 | 2024-12-31 | -3.87 | 2025-03-06 | 10-K |
| Q3 2024 | 2024-09-30 | -6.08 | 2024-11-13 | 10-Q |
| Q2 2025 | 2024-06-30 | -9.17 | 2025-08-11 | 10-Q |
| Q1 2025 | 2024-03-31 | -2.21 | 2025-05-14 | 10-Q |
| FY 2023 | 2023-12-31 | -0.37 | 2024-02-01 | 10-K |
| Q3 2023 | 2023-09-30 | -0.29 | 2023-10-18 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.20 | 2024-08-01 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.09 | 2024-04-25 | 10-Q |
| FY 2023 | 2022-12-31 | -0.69 | 2024-02-01 | 10-K |
| Q3 2023 | 2022-09-30 | -0.61 | 2023-10-18 | 10-Q |
| Q1 2023 | 2022-06-30 | -0.45 | 2023-07-21 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.23 | 2023-04-24 | 10-Q |
| FY 2022 | 2021-12-31 | -1.39 | 2023-02-24 | 10-K |
| Q3 2022 | 2021-09-30 | -0.99 | 2022-10-28 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.67 | 2022-08-02 | 10-Q |
| Q2 2012 | 2012-06-30 | -0.21 | 2012-08-13 | 10-Q |
| Q2 2012 | 2011-06-30 | -0.20 | 2012-08-13 | 10-Q |
| Q2 2011 | 2010-06-30 | -0.58 | 2011-08-15 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.